(Q34016780)

English

In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1

object named as

Tone F Bathen

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

3

object named as

Beathe Sitter

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ingrid Susann Gribbestad

7

object named as

Ingrid S Gribbestad

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Steinar Lundgren

6

object named as

Steinar Lundgren

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Mariann G Heldahl

2

object named as

Mariann G Heldahl

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Riyas Vettukattil

4

object named as

Riyas Vettukattil

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

5

object named as

Anna Bofin

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

10 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Magnetic Resonance Materials in Physics, Biology and Medicine

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

347-357

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

https://scigraph.springernature.com/pub.10.1007/s10334-011-0280-9

0 references

In vivo 1H-MRS evaluation of malignant and benign breast diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy--initial results

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Detection of breast malignancy: diagnostic MR protocol for improved specificity.

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Human breast lesions: characterization with proton MR spectroscopy

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T.

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Metabolite quantification and high-field MRS in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Molecular causes of the aberrant choline phospholipid metabolism in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Advances in functional and structural MR image analysis and implementation as FSL

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

A new automated software system to evaluate breast MR examinations: improved specificity without decreased sensitivity.

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T.

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Interaction of gadolinium-based MR contrast agents with choline: implications for MR spectroscopy (MRS) of the breast

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Study of normal breast tissue by in vivo volume localized proton MR spectroscopy: variation of water-fat ratio in relation to the heterogeneity of the breast and the menstrual cycle.

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

1H MR spectroscopy of invasive ductal carcinoma: correlations with FDG PET and histologic prognostic factors

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Predicting pathological response to neoadjuvant chemotherapy in breast cancer with quantitative 1H MR spectroscopy using the external standard method

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Monitoring the therapeutic response of locally advanced breast cancer patients: sequential in vivo proton MR spectroscopy study

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Detection of choline signal in human breast lesions with chemical-shift imaging

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

External standard method for the in vivo quantification of choline-containing compounds in breast tumors by proton MR spectroscopy at 1.5 Tesla

1 reference

https://api.crossref.org/works/10.1007%2FS10334-011-0280-9

21 January 2018

Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/21909791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathophysiologic basis of contrast enhancement in breast tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21909791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer: Predicting Response with in Vivo1H MR Spectroscopy—A Pilot Study at 4 T

1 reference

https://pubmed.ncbi.nlm.nih.gov/21909791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21909791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21909791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI).

1 reference

https://pubmed.ncbi.nlm.nih.gov/21909791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21909791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10334-011-0280-9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34016780&oldid=1950993184"